Quanterix Corp
General ticker "QTRX" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $445.4M
Quanterix Corp does not follow the US Stock Market performance with the rate: -23.8%.
Estimated limits based on current volatility of 3.8%: low 10.07$, high 10.86$
Factors to consider:
- Current price 41.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [18.18$, 39.08$]
- 2024-12-30 to 2025-12-30 estimated range: [16.25$, 35.54$]
Financial Metrics affecting the QTRX estimates:
- Negative: Non-GAAP EPS, $ of -0.86 <= 0.10
- Negative: Operating profit margin, % of -28.88 <= 1.03
- Negative: Operating cash flow per share per price, % of -1.98 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
Short-term QTRX quotes
Long-term QTRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $110.56MM | $105.52MM | $122.37MM |
| Operating Expenses | $169.14MM | $207.23MM | $172.07MM |
| Operating Income | $-58.59MM | $-101.70MM | $-49.70MM |
| Non-Operating Income | $0.86MM | $5.07MM | $18.09MM |
| Interest Expense | $0.40MM | $5.13MM | $0.00MM |
| R&D Expense | $27.98MM | $25.89MM | $24.86MM |
| Income(Loss) | $-57.72MM | $-96.64MM | $-31.61MM |
| Taxes | $-0.04MM | $0.07MM | $0.72MM |
| Profit(Loss) | $-57.69MM | $-96.70MM | $-32.33MM |
| Stockholders Equity | $440.95MM | $358.94MM | $346.93MM |
| Inventory | $22.19MM | $16.79MM | $22.36MM |
| Assets | $501.53MM | $434.20MM | $425.01MM |
| Operating Cash Flow | $-47.91MM | $-48.27MM | $-18.90MM |
| Capital expenditure | $13.62MM | $11.73MM | $3.79MM |
| Investing Cash Flow | $-6.34MM | $-11.21MM | $-148.40MM |
| Financing Cash Flow | $270.80MM | $2.31MM | $2.69MM |
| Earnings Per Share* | $-1.60 | $-2.61 | $-0.86 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.